Fyn kinase in the dorsomedial striatum (DMS) of rodents plays a central role in mechanisms underlying excessive alcohol intake. The DMS is comprised mostly of medium spiny neurons (MSNs) that are divided into dopamine D1 receptor expressing neurons (dMSNs), and dopamine D2 receptor expressing neurons (iMSNs). Here, we examined the cell-type specificity of Fyn's actions on the development of alcohol use. First, we knocked down Fyn selectively in DMS dMSNs or iMSNs of mice and measured the level of alcohol consumption. We found that downregulation of Fyn in dMSNs, but not in iMSNs, reduces excessive alcohol but not saccharin intake and preference. D1Rs are coupled to Gαs/olf, which activate cAMP signaling. To examine whether Fyn's actions are mediated through cAMP signaling, DMS dMSNs were infected with GαsDREADD, and the activation of Fyn signaling was measured following CNO treatment. We found that remote stimulation of cAMP signaling in DMS dMSNs activates Fyn and promotes the phosphorylation of the Fyn substrate, GluN2B. Next, we tested whether remote activation of GαsDREADD in DMS dMSNs or iMSNs alters alcohol intake, and observed that CNO-dependent activation of GαsDREADD in DMS dMSNs but not iMSNs increases alcohol but not saccharin intake and preference. Finally, we examined the contribution of Fyn to GαsDREADD-dependent increase in alcohol intake, and found that systemic administration of the Fyn inhibitor, AZD0503 blocks GαsDREADD-dependent increase in alcohol consumption.
Introduction
The dorsomedial striatum (DMS) is critically involved in processes such as locomotion (Grillner et al, 2005) , and goal-directed behaviors (Luft and Buitrago, 2005; Redgrave et al, 2010) . The DMS is comprised primarily of GABAergic medium spiny projection neurons (MSNs) that receive dopaminergic input from the midbrain (Bolam et al, 2000) . MSNs can be divided into two populations of neurons that take part in opposing activities (Gerfen and Surmeier, 2011) ; MSNs that project directly to the substantia nigra pars reticula (SNr) facilitate actions and are defined as direct MSNs (dMSNs) (Gerfen et al, 2011) , and MSNs that project indirectly to the SNr gate actions and are defined as indirect MSNs (iMSNs) (Gerfen et al, 2011) . dMSNs selectively express the dopamine D1 receptors (D1Rs) whereas iMSNs express the dopamine D2 receptors (D2Rs) (Gerfen et al, 2011) . In the striatum, D1Rs are coupled to Gαolf, a homolog of Gαs (Herve, 2011) . Stimulation of Gαs/olf-coupled receptors results in the production of the second messenger cyclic adenosine monophosphate (cAMP) (Herve, 2011; Neve et al, 2004) , which binds to, and activates, protein kinase A (PKA) (Taylor et al, 2013) , a kinase that plays an important role in the adult brain (Brandon et al, 1997; Kandel, 2012; Waltereit and Weller, 2003) . In contrast, D2Rs are coupled to Gαi, which inhibits cAMP signaling (Neve et al, 2004) . dMSNs and iMSNs exert balanced influence on locomotion and goal-directed behaviors (Gerfen et al, 2011) , and an imbalance of dMSNs and iMSNs function has been implicated in neurodegenerative disorders such as Parkinson's disease (Gerfen et al, 2011; Ryan et al, 2018) , as well as psychiatric disorders such as obsessive compulsive disorder, anxiety and addiction (Bocarsly et al, 2019; Gunaydin and Kreitzer, 2016; Lobo and Nestler, 2011) .
We previously observed that Fyn kinase is activated in DMS dMSNs upon stimulation of D1Rs (Phamluong et al, 2017) . Fyn belongs to the Src family of non-receptor protein tyrosine kinases (PTKs) (Ingley, 2008; Resh, 1998) , and is highly expressed in the developing and adult brain in regions such as cortex, hippocampus and cerebellum as well as in the striatum (Umemori et al, 1992; Yagi et al, 1993) . Fyn plays an important role in the CNS (Ohnishi et al, 2011) , as it modulates excitatory and inhibitory synaptic transmission and participates in learning and memory processes (Chattopadhyaya et al, 2013; Grant et al, 1992; Hildebrand et al, 2016; Kojima et al, 1997; Ohnishi et al, 2011; Salter and Kalia, 2004; Trepanier et al, 2012; Yaka et al, 2002) . Dysfunction of Fyn signaling has been associated with Alzheimer's disease (Kaufman et al, 2015) and pain (Hildebrand et al, 2016) .
Accumulating data in humans and rodents also suggest that Fyn plays a central role in cellular neuroadaptations that underlie alcohol use disorder (AUD) Ron and Barak, 2016) . Specifically, genetic mutations within the Fyn gene have been associated with increased susceptibility for the development and severity of AUD in humans (Ishiguro et al, 2000; Pastor et al, 2009; Schumann et al, 2003) , and gene network association studies identified a link between Fyn and alcohol dependence (Han et al, 2013) . Animal data suggest that Fyn plays a role in the acute tolerance to the hypnotic sedative effect of alcohol (Miyakawa et al, 1997; Yaka et al, 2003b) , as well as in alcohol drinking behavior (Morisot et al, 2019; Wang et al, 2007; Wang et al, 2010) . Molecularly, excessive consumption of alcohol activates Fyn specifically in the DMS of mice and rats (Darcq et al, 2014; Gibb et al, 2011; Wang et al, 2010) .
Once activated by alcohol, Fyn phosphorylates its substrate, GluN2B (Darcq et al, 2014; Gibb et al, 2011; Wang et al, 2010) . Alcohol-dependent Fyn-mediated phosphorylation of GluN2B results in forward trafficking of the channel and in long-lasting enhancement of GluN2B activity in the DMS (Wang et al, 2010) . Inhibition of Fyn in the DMS of rats attenuates operant selfadministration of alcohol (Wang et al, 2010) , and systemic administration of the Fyn inhibitor, AZD0530, attenuates goal-directed alcohol seeking and facilitates extinction in mice (Morisot et al, 2019) . Together, these data suggest that Fyn in the DMS plays a central role in neuroadaptations that underlie alcohol use.
This study was aimed to explore the cellular specificity of Fyn-dependent molecular and behavioral neuroadaptations that drive AUD.
Methods
The description of purchased reagents and animals, mouse breeding, collection of brain samples, westernblot analysis, preparation of solutions and the preparation of FLEX-shRNA-Fyn and FLEX-SCR is detailed in the Supplementary Information section.
Infection of the DMS with FLEX-shFyn and FLEX-SCR
D1-Cre/Ai1 and A2A-Cre/Ai14 mice were anesthetized using a mixture of ketamine (120 mg/kg) and xylazine (8 mg/kg). Bilateral microinfusions were made using stainless steel injectors (33 gauge, Small Parts) into the DMS (the stereotaxic coordinates were anterioposterior +1.1 mm and +1.3 mm from bregma; mediolateral ±1.2 mm from bregma and dorsoventral -2.8 and -3 mm from the skull surface). Animals were infused with lenti-virus expressing FLEX-shFyn or its scramble control (FLEX-SCR) (1.2 μl/site with 4 sites of injection per hemisphere) at a concentration of 10 7 pg/ml at an injection rate of 0.1 μl/minute (Phamluong et al, 2017) . After each infusion, the injectors were left in place for an additional 10 minutes to allow the virus to diffuse.
Infection of the DMS with AAV-DIO-rM3D(Gs)-mCherry
Drd1a-Cre or A2A-Cre mice were anesthetized using a mixture of ketamine (120 mg/kg) and xylazine (8 mg/kg). Bilateral microinfusions were made using stainless steel injectors (33 gauge, Small Parts) into the DMS (the stereotaxic coordinates were anterioposterior +1.1 mm and +1.3 mm from bregma; mediolateral ±1.25 mm from bregma and dorsoventral -2.8 and -3 mm from the skull surface). Mice were infused with AAV-DIO-rM3D(Gs)-mCherry (AAV-DIO-Gs-DREADD) (1 μl per hemisphere) at a concentration of 10 13 vg/ml and at an injection rate of 0.1 μl/minute. After each infusion, the injectors were left in place for an additional 10 minutes to allow the virus to diffuse.
Drinking Paradigm Two bottle choice -20% alcohol
Mice underwent four weeks of 2-bottle choice 20% (v/v) alcohol drinking paradigm (IA20%2BC) as described in Warnault et al, 2013) . Specifically, one month after stereotaxic surgery and infection of the DMS with FLEX-shFyn or FLEX-SCR, mice had 24 hours access to one bottle of 20% alcohol and one bottle of water on Monday, Wednesday and Friday with alcohol drinking sessions starting 2 hours into the dark cycle.
During the 24 or 48 hours (weekend) of alcohol deprivation periods, mice had access to two bottles of water (Figure 1b) .
Two bottle choice -10% alcohol
One month after stereotaxic surgery and the infection of the DMS of Drd1a-Cre or A2A-Cre with AAV-DIO-Gs-DREADD, mice were habituated by intraperitoneal (IP) injection of saline for three days. On test day, mice received a systemic administration of vehicle (0.5% DMSO) or CNO (3 mg/kg). Fifteen minutes later, mice had access to one bottle of 10% (v/v) alcohol and one bottle of water. Alcohol and water intake were measured 4 hours later (Timeline, Figure   3a ). Mice were then given water only for one week and were tested again using a counterbalanced, within-subject design.
A separate cohort of Drd1a-Cre mice were infected with AAV-DIO-Gs-DREADD in the DMS.
One month later, mice were systemically administered with vehicle (20% HPBCD) or AZD0530 (10 mg/kg) 3 hours prior to the beginning of the drinking session. Subsequently, animals received a systemic administration of vehicle (0.5% DMSO) or Clozapine N-Oxide (CNO, 3 mg/kg) 15 minutes before the beginning of the drinking session, and alcohol and water intake were measured 4 hours later (Timeline, Figure 4a ). Mice were tested in a counterbalanced, within-subjects design.
Two bottle choice -0.03% Saccharin
Mice underwent a saccharin intake procedure as described in (Ben Hamida et al, 2012) .
Specifically, 2 weeks after the end of the alcohol drinking paradigm during which mice consumed only water, mice had access to one bottle of water and one bottle of saccharin (0.03%) every other day for 1 week (2 sessions) (Timeline, Figure 1b) .
The DMS of a separate cohort of Drd1a-Cre mice were infected with AAV-DIO-Gs-DREADD.
On test day, mice received a systemic administration of vehicle (0.5% DMSO) or CNO (3 mg/kg). Fifteen minutes later, mice had access to a bottle of saccharin (0.03%) and one bottle of water. Saccharin and water intake were measured 4 hours later (Timeline, Figure 3a ). Mice were then given water only for one week and were tested again using a counterbalanced, withinsubject design.
Alcohol (g/kg), saccharin (ml/kg) and water (ml/kg) intake were recorded at the end of each 4hour drinking session, and preference ratio (alcohol/alcohol+water or saccharin/saccharin+water) was calculated. The placement (right or left) of the bottles was alternated in each session to control for side preference. Spillage was monitored using an additional water bottle in a nearby unused cage.
Statistical analysis
GraphPad Prism 7.0 (GraphPad Software, Inc., La Jolla, CA, USA) was used to plot and analyze the data. D'Agostino-Pearson normality test and F-test/Levene tests were used to verify the normal distribution of variables and the homogeneity of variance, respectively. Data were analyzed using the appropriate statistical test, including two-tailed unpaired or paired t-test, twoway analysis of variance (ANOVA) followed by post hoc tests as detailed in the Figure Legends .
Experiments designed to evaluate the consequence of Fyn knockdown using FLEX-shFyn were analyzed with unpaired t-test. Experiments designed to test the contribution of cAMP signaling on alcohol intake using AAV-DIO-Gs-DREADD were analyzed with paired t-test since within subject design was used. All data are expressed as mean ± SEM, and statistical significance was set at p<0.05.
Results
To determine whether Fyn's actions are localized to DMS dMSNs and/or iMSNs, we used transgenic mice which express Cre recombinase and tdTomato specifically in dMSNs (Drd1-Cre-Ai14), or that express Cre recombinase and tdTomato specifically in iMSNs (A2A-Cre-Ai14), in combination with a Cre-dependent Flip Excision (FLEX) approach to downregulate Fyn mRNA in dMSNs or iMSNs, respectively, as described in (Phamluong et al, 2017) . First, we examined the consequence of Fyn knockdown in DMS dMSNs on alcohol drinking. To do so, the DMS of Drd1-Cre-Ai14 was infected bilaterally with a lentivirus expressing a short hairpin mRNA sequence targeting Fyn inserted in a FLEX cassette (FLEX-shFyn) (10 7 pg/ml, 1.2 μl per site) or with a FLEX virus expressing a scramble sequence which was used as a control (FLEX-SCR, 10 7 pg/ml, 1.2 μl per site) (Figure 1a) . After 4 weeks, which enabled maximal viral infection and knockdown of the gene (Phamluong et al, 2017) , mice were subjected to 4 weeks of IA20%2BC and alcohol intake was measured at the final 4-hours drinking session (Timeline, Figure 1b ). Alcohol intake (Figure 1c , Supplementary Table 1) and preference (Figure 1d ) were significantly reduced in Drd1-Cre-Ai14 mice infected with FLEX-shFyn in dMSNs as compared to the FLEX-SCR infected mice.
Next, to determine if downregulation of Fyn in iMSNs also affects alcohol intake, the DMS of A2A-Cre-Ai14 mice was infected with FLEX-shFyn or FLEX-SCR. Four weeks later, mice underwent an IA20%2BC for 4 weeks and alcohol intake and preference were measured (Timeline, Figure 1b ). Knockdown of Fyn in iMSNs did not alter alcohol intake (Figure 1e , Supplementary Table 1 ) or preference (Figure 1f) . Together, these data suggest that Fyn participates in mechanisms underlying alcohol consumption through its actions in dMSNs but not in iMSNs.
We then assessed whether Fyn's action in DMS dMSNs is specific for alcohol or is shared with other rewarding substances. To examine this question, we tested the consequences of Fyn knockdown in DMS dMSNs on the consumption of 0.03% saccharin (Timeline Figure 1b) . Figure 1g -h, knockdown of Fyn in DMS dMSNs did not alter saccharin intake (Figure 1g , Supplementary Table 1 ) or preference (Figure 1e ) suggesting that Fyn's regulation of consummatory behavior in DMS dMSNs is specific for alcohol, and is not generalized to other reinforcing agents.
As shown in
As stated above, D1Rs are selectively expressed in dMSNs (Gerfen et al, 2011) . D1Rs are coupled to Gαs/olf, and stimulation of Gαs/olf-coupled receptors activates cAMP/PKA signaling (Herve, 2011; Neve et al, 2004) . Ex vivo data suggest that Fyn is activated in the hippocampal neurons through the cAMP/PKA pathway (Goebel-Goody et al, 2012; Thornton et al, 2004; Trepanier et al, 2012; Yaka et al, 2003a) . We therefore postulated that stimulation of cAMP/PKA signaling in DMS dMSNs activates Fyn. To test this possibility, we utilized the Designer Receptor Exclusively Activated by Designer Drug (DREADD) system to remotely activate Gαs in DMS dMSNs or iMSNs (Farrell et al, 2013) . First, the DMS of Drd1-Cre mice was infected bilaterally with AAV8-hSyn-DIO-rM3D(Gs)-mCherry (10 13 vg/ml, 1 μl per hemisphere) (Figure 2a) . Four weeks after surgery, vehicle or CNO (3 mg/kg) was administered systemically, and the DMS was harvested 30 minutes later (Timeline, Figure 2b) . As shown in Figure 2c-d , CNO administration produced a robust activation of Fyn in the DMS. We also measured the phosphorylation level of the Fyn substrate, GluN2B (Trepanier et al, 2012) , and found that Fyn activation in dMSNs was accompanied by the phosphorylation of GluN2B (Figure 2e-f) . In contrast, CNO administration did not alter Fyn's activity or GluN2B phosphorylation in the DLS, a neighboring striatal region which was not infected with AAV8-hSyn-DIO-rM3D(Gs)-mCherry (Figure 3c-f) . Together, these data suggest that Fyn signaling is enhanced in response to remote activation of GαsDREADD in DMS dMSNs.
We then determined whether the cAMP-dependent activation of Fyn in dMSNs alters alcohol drinking. As Drd1-Cre mice consume large quantities of 20% alcohol ( (Wang et al, 2015) , Figure 1c ), we used a lower concentration (10% v/v) in order to avoid a confounding ceiling effect of alcohol intake due to GαsDREADD activation. The DMS of Drd1-Cre mice was infected bilaterally with AAV-hSyn-DIO-rM3D(Gs)-mCherry, four weeks later, vehicle or CNO (3 mg/kg) was administered systemically 15 minutes before the beginning of a 10% alcohol drinking session, and alcohol intake was measured after 4 hours (Timeline, Figure 3a) . As shown in Figure 3b -c, remote activation of GαsDREADD in DMS dMSNs significantly increased alcohol intake (Figure 3b, Supplementary Table 1 ) and preference (Figure 3c) . We then examined whether remote activation of GαsDREADD in DMS iMSNs also alters alcohol intake. Interestingly, CNO administration did not alter alcohol intake (Figure 3d , Supplementary Table 1 ) or preference (Figure 3e) in DMS iMSNs suggesting that cAMP signaling in dMSNs but not iMSNs contributes to the development of alcohol consumption.
Gomez et al. reported that CNO is converted to clozapine prior to binding and activating
DREADDs (Gomez et al, 2017) , and furthermore, CNO was reported to produce some behavioral effects on its own (Goutaudier et al, 2019; MacLaren et al, 2016) . Therefore, to ensure that the increase in alcohol intake was not due to off-target effects of the drug, we measured the level of alcohol consumption upon vehicle or CNO (3 mg/kg) treatment in Drd1-Cre mice that were not infected with AAV-hSyn-DIO-rM3D(Gs)-mCherry (Timeline, Supplementary Figure 1a) . CNO administration did not alter alcohol intake or preference in uninfected Drd1-Cre mice (Supplementary Figure 1b-c, Supplementary Table 1 ) suggesting that the increase in alcohol intake by CNO-dependent activation of GαsDREADD in DMS dMSNs is not due to off target effects of the drug itself or its metabolite, clozapine.
Next, we examined whether remote activation of GαsDREADD in DMS dMSNs alters the consumption of saccharin. Two weeks after the end of the alcohol drinking experiment, vehicle or CNO (3 mg/kg) was administered systemically 15 minutes prior to the initiation of the saccharin (0.03%) drinking session, and saccharin intake was measured after 4 hours (Timeline, Figure 3a ). Activation of GαsDREADD in dMSNs did not alter saccharin intake (Figure 3f , Supplementary Table 1 ) or preference (Figure 3f) suggesting that the increase in consumption upon activation of GαsDREADD in DMS dMSNs is specific for alcohol.
Finally, we set out to test whether Fyn is required for GαsDREADD-dependent increase in alcohol consumption. To test this possibility, the DMS of Drd1-Cre mice was infected bilaterally with AAV-hSyn-DIO-rM3D(Gs)-mCherry, four weeks later, vehicle or the Src/Fyn inhibitor AZD0530 (10 mg/kg) (Hennequin et al, 2006; Kaufman et al, 2015; Morisot et al, 2019) was administered 3 hours before the beginning of the 10% alcohol drinking session followed by the administration of vehicle or CNO (3 mg/kg) 15 minutes prior to the start of the session, and alcohol intake was measured after 4 hours (Timeline, Figure 4a ). In accordance with Figure 3b , the amount of alcohol consumed by mice was elevated after the remote activation of GαsDREADD in DMS dMSNs, but the increase in alcohol intake was blocked when AZD0530 was administered prior to CNO (Figure 4b, Supplementary Table 1) . These results suggest alcohol intake is driven through the cAMP/PKA/Fyn signaling in DMS dMSNs.
Discussion
Here, we present data to suggest that cAMP/PKA-dependent activation of Fyn kinase in the DMS dMSNs participates in mechanisms underlying the development of excessive alcohol intake. Specifically, we show that downregulation of Fyn levels in DMS dMSNs prior to the initiation of the IA20%2BC regimen attenuates alcohol intake. We further report that the stimulation of Gαs signaling in DMS dMSNs activates Fyn/GluN2B signaling, and enhances alcohol intake in a Fyn-dependent manner. In contrast, knockdown of Fyn or activation of cAMP signaling in iMSNs does not alter alcohol intake and preference. Finally, we show that the cAMP/Fyn signaling in DMS dMSNs is specific for alcohol and does not contribute to mechanisms underlying consummatory behavior per se. Based on previous data showing that Fyn is activated in the DMS through the stimulation of D1R in DMS dMSNs (Phamluong et al, 2017) , and since dopamine levels in the dorsal striatum are elevated by drugs of abuse including alcohol (Di Chiara and Imperato, 1988; Lof et al, 2007) , we propose a model in which dopamine released in the DMS in response to alcohol exposure stimulates D1R/cAMP/PKA signaling in dMSNs which in turn activates Fyn to initiate neuroadaptations such as GluN2B phosphorylation that promote the development of alcohol use (Supplementary Figure 2) .
Our data suggest that Fyn in DMS dMSNs contributes to the development of alcohol consumption. The DMS is essential for goal-directed behaviors (Luft et al, 2005; Redgrave et al, 2010) , and dMSNs contribute to reward learning and reinforcement (Hikida et al, 2010; Kravitz et al, 2012) . Thus, it is plausible that Fyn in dMSNs promotes reward learning which in turn initiates and maintains goal-directed alcohol seeking. This possibility is in line with recent findings demonstrating that systemic administration of the Src/Fyn inhibitor, AZD0530, attenuates goal-directed alcohol self-administration in mice (Morisot et al, 2019) . Xie et al. previously showed that administration of the Src/Fyn inhibitor PP2 into the dorsal hippocampus attenuates context-dependent cocaine seeking (Xie et al, 2013) , and more recently, Belin-Rauscent reported that oral administration of the Src PTKs inhibitor, Masitinib, attenuates selfadministration of cocaine (Belin-Rauscent et al, 2018) . Thus, it would be of interest to determine whether Fyn in DMS dMSNs contributes to goal-directed seeking of other drugs of abuse.
Furthermore, Goto et al. previously reported that mating behavior increases PKA activity in dorsal striatal dMSNs (Goto et al, 2015) . As PKA in DMS dMSNs is upstream of Fyn, it is plausible that the Fyn in these neurons plays a role in other goal-directed behaviors such as mating. Finally, recently, Bocarsly et al. recently showed that enhanced D1R signaling in the dorsal striatum of mice is required for the consumption of alcohol despite negative consequences, and for the enhancement of alcohol-dependent hyperlocomotion (Bocarsly et al, 2019) . Therefore, it plausible that Fyn in DMS dMSNs also contributes to other alcoholdependent behaviors.
We report that stimulation of the cAMP/PKA signaling in DMS dMSNs activates Fyn signaling. To do so, we utilized anti-phosphoTyrosine417/420 antibodies which recognize the autophosphorylated active form of the kinase (Ingley, 2008; Resh, 1998) . The anti-phosphoTyrosine417/420 antibodies do not distinguish between active Fyn and Src. However, we are confident that we detected the specific activation of Fyn and not Src as neither alcohol exposure (Wang et al, 2007) nor D1R stimulation (Phamluong et al, 2017) activates Src in the dorsal striatum.
The data herein and previous findings suggest that Fyn exerts its action on alcohol drinking in dMSNs through the phosphorylation and activation of GluN2B.
However, we cannot exclude the possibility that other molecular transducers of Fyn contribute to the development of alcohol use. For example, protein translation plays a critical role in mechanisms underlying AUD (Laguesse and Ron, 2019) , and Fyn was shown to enhance protein translation in oligodendrocytes (White et al, 2008) and in neurons (Li and Gotz, 2017) . Fyn was also shown to promote ERK1/2 phosphorylation in oligodendrocytes (Peckham et al, 2016) , and NfkB signaling in microglia (Panicker et al, 2015) ; both signaling cascades have been linked to alcohol use (Crews et al, 2011; Ron et al, 2016) . Finally, Fyn was reported to phosphorylate the metabotropic glutamate receptor 1 (mGluR1) (Jin et al, 2017) 
and the Collapsin Response
Mediator Protein 2 (CRMP2) (Uchida et al, 2009) , which have also been implicated in alcohol's actions in the brain Olive, 2010) . Exploring the contribution of these substrates and others in DMS dMSNs to the neuroadaptations underlying AUD merit further investigation.
Finally, it is highly likely that the activation of PKA in DMS dMSNs produces additional cellular consequences. For example, PKA phosphorylates the Striatal-Enriched Protein Tyrosine Phosphatase (STEP) (Goebel-Goody et al, 2012) resulting in the inhibition of the activity of the phosphatase (Goebel-Goody et al, 2012) . STEP is an endogenous Fyn inhibitor and is responsible for the termination of Fyn activation (Goebel-Goody et al, 2012) . We previously reported that alcohol increases PKA phosphorylation of STEP in the DMS, and that knockdown of STEP in the DMS (Darcq et al, 2014) , or global knockout of the phosphatase (Legastelois et al, 2015) increases alcohol intake. It is therefore plausible that one of the consequence of PKA activation in DMS dMSNs is the phosphorylation of STEP, enabling Fyn in these neurons to stay active for a prolonged period of time.
Using the DREAD/CNO methodology, we report that the activation of GαsDREADD in dMSNs but not in iMSNs initiates the consumption of alcohol. We further show that GαsDREADD-dependent increase in alcohol intake dependent, at least in part, on Fyn. To our knowledge this is the first study that provides a link between GαsDREADD activation and alcohol consummatory behavior. Cheng et al. previously showed that GαiDREADD-mediated inhibition of iMSNs enhances alcohol intake (Cheng et al, 2017) . Stimulation of Gαs-couled receptors activates adenylate cyclase that increases cAMP production, whereas the stimulation of Gαi-coupled receptors inhibits adenylate cyclase activity and cAMP production (Neve et al, 2004) . Thus, it is plausible that the development of alcohol consumption depends on the inhibition of cAMP signaling in iMSNs and on the activation of cAMP signaling in dMSNs.
Interestingly, neither Fyn knockdown in dMSNs nor CNO-dependent activation of GαsDREADD in DMS dMSNs alters the intake of saccharin suggesting that the contribution of this signaling cascade cannot be generalized to all consummatory behaviors. Our model (Supplementary Figure 2) suggests that alcohol activates Fyn in DMS dMSNs through dopamine-dependent D1R stimulation. Dopamine is not required for sucrose and saccharin consumption (Cannon and Palmiter, 2003) . Thus, it is plausible that the requirement of dopamine release in the dorsal striatum is the differentiating factor between the molecular mechanisms underlying the consumption of alcohol vs. sweetened solutions.
Our data suggest that alcohol-dependent molecular adaptations are highly specific and are segregated to a subpopulation of neurons. Future studies are necessary to determine whether this cell-type specificity is unique for the cAMP/PKA/Fyn signaling or that this is a common feature shared by some or all of the molecular targets of alcohol (Ron et al, 2016) .
Although we provide a strong evidence linking PKA signaling in dMSNs to alcohol drinking behaviors, we cannot exclude the possibility that other cAMP effectors such as the guanine nucleotide exchange factor EPAC (exchange protein directly activated by cAMP) (Schmidt et al, 2013) , and/or cyclic nucleotide-gated ion channels (CNGC) (Kaupp and Seifert, 2002 ) also contribute to the development of excessive alcohol use. Finally, further research is required to monitor cAMP production and PKA activation in behaving animals. Recent advances in the development of reporters for cAMP (Muntean et al, 2018) , and PKA (Ma et al, 2018) will enable a spatial and temporal analysis of cAMP/PKA signaling in animals consuming alcohol.
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